Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
Public ClinicalTrials.gov record NCT00002241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Efficacy of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 100 Mg/d4T/3TC b.i.d. in HIV-Infected Individuals
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see whether taking indinavir (IDV) plus ritonavir (RTV) plus stavudine (d4T) plus lamivudine (3TC) 2 times each day is safe and can lower the level of HIV in the blood.
Study identification
- NCT ID
- NCT00002241
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Apogee Med Group | San Diego | California | 92101 | — |
| Univ of California at San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| HIV Institute / Davies Med Ctr | San Francisco | California | 94114 | — |
| Kaiser Foundation Hospital | San Francisco | California | 94118 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| AIDS Research Alliance - Chicago | Chicago | Illinois | 60657 | — |
| Tulane Univ School of Medicine | New Orleans | Louisiana | 70112 | — |
| CRI New England | Brookline | Massachusetts | 02146 | — |
| SUNY Health Sciences Ctr | Brooklyn | New York | 11203 | — |
| Chelsea Village Med Ctr | New York | New York | 10014 | — |
| Liberty Med Group | New York | New York | 10016 | — |
| St Lukes / Roosevelt Hosp / HIV Center | New York | New York | 10019 | — |
| Mount Sinai Med Ctr | New York | New York | 10029 | — |
| Bronx Lebanon Hosp Ctr | The Bronx | New York | 10456 | — |
| Montefiore Med Ctr | The Bronx | New York | 10467 | — |
| Mark Watkins | Philadelphia | Pennsylvania | 19107 | — |
| Univ of Texas / Thomas Street Clinic | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002241 live on ClinicalTrials.gov.